A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol

Chantal P Bleeker-Rovers, Fidel J Vos, Elisabeth M H A de Kleijn, Aart H Mudde, Ton S M Dofferhoff, Clemens Richter, Tineke J Smilde, Paul F M Krabbe, Wim J G Oyen, Jos W M van der Meer, Chantal P Bleeker-Rovers, Fidel J Vos, Elisabeth M H A de Kleijn, Aart H Mudde, Ton S M Dofferhoff, Clemens Richter, Tineke J Smilde, Paul F M Krabbe, Wim J G Oyen, Jos W M van der Meer

Abstract

We conducted a prospective study to update our knowledge of fever of unknown origin (FUO) and to explore the utility of a structured diagnostic protocol. From December 2003 to July 2005, 73 patients with FUO were recruited from 1 university hospital (n = 40) and 5 community hospitals (n = 33) in the same region in The Netherlands. FUO was defined as a febrile illness of >3 weeks' duration, a temperature of >38.3 degrees C on several occasions, without a diagnosis after standardized history-taking, physical examination, and certain obligatory investigations. Immunocompromised patients were excluded. A structured diagnostic protocol was used. Patients from the university hospital were characterized by more secondary referrals and a higher percentage of periodic fever than those referred to community hospitals. Infection was the cause in 16%, a neoplasm in 7%, noninfectious inflammatory diseases in 22%, miscellaneous causes in 4%, and in 51%, the cause of fever was not found (no differences between university and community hospitals). There were no differences regarding the number and type of investigations between university and community hospitals. Significant predictors for reaching a diagnosis included continuous fever; fever present for <180 days; elevated erythrocyte sedimentation rate, C-reactive protein, or lactate dehydrogenase; leukopenia; thrombocytosis; abnormal chest computed tomography (CT); and abnormal F-fluorodeoxyglucose positron emission tomography (FDG-PET). For future FUO studies, inclusion of outpatients and the use of a set of obligated investigations instead of a time-related criterion are recommended. Except for tests from the obligatory part of our protocol and cryoglobulins in an early stage, followed by FDG-PET, and in a later stage by abdominal and chest CT, temporal artery biopsy in patients aged 55 years or older, and possibly bone marrow biopsy, other tests should not be used as screening investigations.

References

    1. Arnow PM, Flaherty JP. Fever of unknown origin. Lancet. 1997;350:575-580.
    1. Barbado FJ, Vazquez JJ, Pena JM, et al. Pyrexia of unknown origin: changing spectrum of diseases in two consecutive series. Postgrad Med J. 1992;68:884-887.
    1. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29-37.
    1. Blockmans D, Knockaert D, Maes A, et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis. 2001;32:191-196.
    1. Brusch JL, Weinstein L. Fever of unknown origin. Med Clin North Am. 1988;72:1247-1261.
    1. Buysschaert I, Vanderschueren S, Blockmans D, et al. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med. 2004;15:151-156.
    1. de Kleijn EM, van der Meer JW. Fever of unknown origin (FUO): reporton 53 patients in a Dutch university hospital. Neth J Med. 1995;47:54-60.
    1. de Kleijn EM, van der Meer JW. Inquiry into the diagnostic workup of patients with fever of unknown origin. Neth J Med. 1997;50:69-74.
    1. de Kleijn EM, van Lier HJ, van der Meer JW. Fever of unknown origin (FUO). II. Diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:401-414.
    1. de Kleijn EM, Vandenbroucke JP, van der Meer JW. Fever of unknown origin (FUO). I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:392-400.
    1. Durack DT, Street AC. Fever of unknown origin-reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35-51.
    1. Ergonul O, Willke A, Azap A, et al. Revised definition of "fever of unknown origin": limitations and opportunities. J Infect. 2005;50:1-5.
    1. Esposito AL, Gleckman RA. A diagnostic approach to the adult with fever of unknown origin. Arch Intern Med. 1979;139:575-579.
    1. Fautrel B, Zing E, Golmard JL, et al. Proposal for a new set of classification criteria for adult-onset Still disease. Medicine (Baltimore). 2002;81:194-200.
    1. Gleckman R, Crowley M, Esposito A. Fever of unknown origin: a view from the community hospital. Am J Med Sci. 1977;274:21-25.
    1. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
    1. Holtz T, Moseley RH, Scheiman JM. Liver biopsy in fever of unknown origin. A reappraisal. J Clin Gastroenterol. 1993;17:29-32.
    1. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-1128.
    1. Kazanjian PH. Fever of unknown origin: review of 86 patients treated in community hospitals. Clin Infect Dis. 1992;15:968-973.
    1. Kjaer A, Lebech AM, Eigtved A, et al. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622-626.
    1. Knockaert DC, Dujardin KS, Bobbaers HJ. Long-term follow-up of patients with undiagnosed fever of unknown origin. Arch Intern Med. 1996;156:618-620.
    1. Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med. 2003;253:263-275.
    1. Knockaert DC, Vanneste LJ, Bobbaers HJ. Fever of unknown origin in elderly patients. J Am Geriatr Soc. 1993;41:1187-1192.
    1. Knockaert DC, Vanneste LJ, Bobbaers HJ. Recurrent or episodic fever of unknown origin. Review of 45 cases and survey of the literature. Medicine (Baltimore). 1993;72:184-196.
    1. Knockaert DC, Vanneste LJ, Vanneste SB, et al. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med. 1992;152:51-55.
    1. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun. 2001;22:779-783.
    1. Meller J, Altenvoerde G, Munzel U, et al. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med. 2000;27:1617-1625.
    1. Mitchell DP, Hanes TE, Hoyumpa AM Jr, et al. Fever of unknown origin. Assessment of the value of percutaneous liver biopsy. Arch Intern Med. 1977;137:1001-1004.
    1. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3:55-78.
    1. Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med. 1992;152:21-22.
    1. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961;40:1-30.
    1. Quinn MJ, Sheedy PF, Stephens DH, et al. Computed tomography of the abdomen in evaluation of patients with fever of unknown origin. Radiology. 1980;136:407-411.
    1. Saltoglu N, Tasova Y, Midikli D, et al. Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year-period of study. J Infect. 2004;48:81-85.
    1. Tabak F, Mert A, Celik AD, et al. Fever of unknown origin in Turkey. Infection. 2003;31:417-420.
    1. Vanderschueren S, Knockaert D, Adriaenssens T, et al. From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med. 2003;163:1033-1041.
    1. Wanvarie S, Tanphaichitra D, Limsuwan A. Fever of unknown origin: a review of 25 cases in Ramathibodi Hospital. J Med Assoc Thai. 1981;64:155-158.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere